UNITED STATES

SECURITIES AND EXCHANGE COMMISSION 

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (date of earliest event reported): July 1, 2021

 

CEL-SCI CORPORATION

(Exact name of Registrant as specified in its charter)

 

Colorado

 

001-11889

 

84-0916344

(State or other jurisdiction

of incorporation)

 

(Commission File No.)

 

(IRS Employer

Identification No.)

 

8229 Boone Blvd., #802

Vienna, VA 22182

(Address of principal executive offices, including Zip Code)

 

Registrant’s telephone number, including area code: (703) 506-9460

 

N/A 

(Former name or former address if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-14c))

 

Title of each class

 

Trading Symbol(s)

 

Name of each exchange on which registered

Common Stock

 

CVM

 

NYSE American

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§203.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§204.12b-2 of this chapter.

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

  

Item 5.07. Submission of Matters to a Vote of Securities Holders.

 

The annual meeting of CEL-SCI’s shareholders was held on July 1, 2021. At the meeting the following persons were elected as directors for the upcoming year:

 

Name

 

Votes For

 

Votes Against

 

Broker

Non-Votes

Geert Kersten

 

14,762,163

 

1,105,807

 

9,654,456

Peter Young

 

12,922,010

 

2,945,960

 

9,654,456

Bruno Baillavoine

 

14,210,050

 

1,657,920

 

9,654,456

Robert Watson

 

14,230,777

 

1,637,193

 

9,654,456

 

At the meeting the following were approved by CEL-SCI’s shareholders:

 

 

(2)

the adoption of CEL-SCI’s 2021 Non-Qualified Stock Option Plan which provides that up to 1,800,000 shares of common stock may be issued upon the exercise of options granted pursuant to the Plan; and

 

 

 

 

(3)

the appointment of BDO USA, LLP as CEL-SCI’s independent registered public accounting firm for the fiscal year ending September 30, 2021.

 

The following is a tabulation of votes cast with respect to proposals 2 and 3:

 

Proposal

 

Votes For

 

Votes Against

 

Abstain

 

Broker

Non-Votes

(2)

 

11,685,526

 

3,844,502

 

337,942

 

9,654,456

(3)

 

25,069,133

 

236,969

 

216,324

 

-

 

 

2

 

  

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

  CEL-SCI CORPORATION
       
Date: July 1, 2021 By: /s/ Geert Kersten

 

 

Geert Kersten  
    Chief Executive Officer  

 

 

3

 

Cel Sci (AMEX:CVM)
Historical Stock Chart
From Aug 2021 to Sep 2021 Click Here for more Cel Sci Charts.
Cel Sci (AMEX:CVM)
Historical Stock Chart
From Sep 2020 to Sep 2021 Click Here for more Cel Sci Charts.